Clinical Trial Update: Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of NS-229 versus placebo in patients with eosinophilic granulomatosis with polyangiitis; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis

Drugs mentioned

• NS-229

Snippet

Sponsor: NS Pharma, Inc. | Conditions: Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome | Phase 2 | Status: RECRUITING